Somatic mutations in cervicovaginal samples: assessing their role in ovarian cancer detection and prognosis
DNA somatic variants in cervicovaginal samples have limited diagnostic value for detecting ovarian cancer. However, their presence may have prognostic significance, warranting further investigation. Future research could explore multimodal strategies that integrate molecular markers with imaging or other approaches to improve early detection.
Authors
- Marta López-Querol (ORCID: https://orcid.org/0000-0001-7158-7652)
- Eduard Dorca (ORCID: https://orcid.org/0000-0003-0658-0096)
- Lara Pijuán (ORCID: https://orcid.org/0000-0002-9978-6933)
- Beatriz Pelegrina (ORCID: https://orcid.org/0000-0002-9832-1165)
- Fátima Marín (ORCID: https://orcid.org/0000-0003-3534-0091)
- Sònia Paytubi (ORCID: https://orcid.org/0000-0002-5392-953X)
- Yolanda Jesus Mendieta Benavente (ORCID: https://orcid.org/0000-0002-0250-2237)
- José Manuel Martínez (ORCID: https://orcid.org/0000-0002-8322-7694)
- Brunet Joan
- Jordi Ponce
- August Vidal
- Laia Alemany
- Marc Barahona
- Yolanda Pérez-Escanilla
- Jon Frias-Gomez
- Irene Onieva
- Claudia Pavon-Diaz
- Laura Costas
- Sergi Fernandez-Gonzalez
Institutions
- Bellvitge University Hospital (ES)
- Hospital Universitari Arnau de Vilanova (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Institut Català d'Oncologia (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1016/j.tranon.2026.102712
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00